One-year follow-up evaluation of magnetic resonance imaging of the brain in dogs with pituitary-dependent hyperadrenocorticism

Journal of the American Veterinary Medical Association

Volumn 208, Issue 8, 1996, Pages 1268-1273

  Bertoy, Elizabeth Herst ^a   Feldman, Edward C ^a   Nelson, Richard W ^a   Dublin, Arthur B ^b   Reid, Michael H ^b   Feldman, Marsha S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Diagnostic Digital Imaging   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; MITOTANE;

ADRENAL CORTEX HYPERFUNCTION; ANIMAL; ANIMAL DISEASE; ARTICLE; DOG; DOG DISEASE; FEMALE; FOLLOW UP; HYPOPHYSIS TUMOR; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSPECTIVE STUDY;

ADRENOCORTICAL HYPERFUNCTION; ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; DOG DISEASES; DOGS; FEMALE; FOLLOW-UP STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MITOTANE; PITUITARY NEOPLASMS; PROSPECTIVE STUDIES;

EID: 0030584866     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Feldman EC. Distinguishing dogs with functioning adrenocortical tumors from dogs with pituitary-dependent hyperadrenocorticism. J Am Vet Med Assoc 1983;183:195-200.
2. Capen CC, Martin SL, Koestner A. Neoplasms in the adenohypophysis of dogs. A clinical and pathologic study. Vet Pathol 1967;4:301-325.
3. Peterson ME, Krieger DT, Drucker WD, et al. Immunochemical study of the hypophysis in 25 dogs with pituitary-dependent hyperadrenocorticism. Acta Endocrinol (Copenh) 1982;101:15-24.
4. Feldman EC, Nelson RW. Canine and feline endocrinology and reproduction. Philadelphia: WB Saunders Co, 1987;137-194.
5. Capen CC, Martin SL. Diseases of the pituitary gland. In: Ettinger SJ, ed. Textbook of veterinary internal medicine. Philadelphia: WB Saunders Co, 1983;1523-1550.
6. Nakamura T, Schorner W, Felix R. The value of paramagnetic contrast gadolinium-DTPA in the diagnosis of pituitary adenomas. Neuroradiology 1988;30:481-486.
7. Bertoy EH, Feldman EC, Nelson RW, et al. Magnetic resonance imaging of the brain in dogs with recently diagnosed but untreated pituitary-dependent hyperadrenocorticism. J Am Vet Med Assoc 1995;206:651-656.
8. Dow SW, LeCouteur RA, Rosychuk RAW, et al. Response of dogs with functional pituitary macroadenomas and macrocarcinomas to radiation. J Small Anim Pract 1990;31:287-294.
9. Nelson RW, Ihle SL, Feldman EC. Pituitary macroadenomas and macroadenocarcinomas in dogs treated with mitotane for pituitary-dependent hyperadrenocorticism: 13 cases (1981-1986). J Am Vet Med Assoc 1989;194:1612-1617.
10. Safarty D, Carillo JM, Peterson ME. Neurologic, endocrinologic, and pathologic findings associated with large pituitary tumors in dogs: eight cases (1976-1984). J Am Vet Med Assoc 1988; 193:854-856.
11. Duesberg CA, Feldman EC, Nelson RW, et al. Magnetic resonance imaging for diagnosis of pituitary macrotumors in dogs. J Am Vet Med Assoc 1995;206:657-662.
12. Kintzer PP, Peterson ME. Mitotane (o,p'-DDD) treatment of 200 dogs with pituitary-dependent hyperadrenocorticism. J Vet Intern Med 1991;5:182-190.
13. Biller BMK. Pathogenesis of pituitary Cushing's syndrome. Endocrinol Metab Clin North Am 1994;23:547-554.
14. Nelson RW, Feldman EC, Shinsako J. Effect of o,p'DDD therapy on endogenous ACTH concentrations in dogs with hypophysis-dependent hyperadrenocorticism. Am J Vet Res 1985;46: 1534-1537.
15. Kasperlik-Zaluska AA, Nielubuwicz J, Wislawski J, et al. Nelson's syndrome: incidence and prognosis. Clin Endocrinol 1983; 19:693-698.
16. Mauldin GN, Burk RL. The use of diagnostic computerized tomography and radiation therapy in canine and feline hyperadrenocorticism. Probl Vet Med 1990;2:557-564.
17. Klibanski A, Zervas NT. Diagnosis and management of hormone-secreting pituitary adenomas. N Engl J Med 1991;324:822-831.
18. Kaye TB, Crapo LC. The crushing syndrome: an update on diagnostic tests. Ann Intern Med 1990;112:434-444.